STNE
StoneCoCAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
The immediate market read was not a durable positive reaction: checked pricing showed STNE opened May 15 at $9.97, traded as high as $10.30, but finished near the $9.61 anchor. Available T+3 analyst evidence is thin but cautious, with BTIG lowering its target and Citi reportedly moving to Neutral. Social evidence was not provided in the packet, so this remains a low-conviction monitoring view driven mainly by the 1Q26 primary filing and limited delayed sell-side digestion.
Evidence flagged
later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
AI events
Stone reported 1Q26 total revenue and income up 6.5% y/y to R$3.578 billion and adjusted basic EPS up 15.4% y/y to R$2.19, helped by credit growth and buybacks, but adjusted gross profit was flat y/y, provisions rose 51.6% q/q, cost of risk reached 21.9%, and NPL >90 days rose to 6.98%; the next debate is whether credit scaling can continue without further reserve pressure or churn-driven TPV weakness [#6K-1Q26-EX99.1].
Available post-print coverage shows BTIG cut its STNE target to $15 from $22 while keeping Buy, citing weak results and credit issues, and Fintel reported Citi downgraded STNE from Buy to Neutral on May 15; this supports a cautious revision signal, but the evidence is still limited and should not be treated as a broad analyst capitulation.
Stone paid a one-time extraordinary dividend of US$2.53 per share tied to Linx-sale proceeds, and its IR guidance page still shows 2026 guidance of R$6.6-7.0 billion adjusted gross profit and R$10.8-11.4 adjusted basic EPS; that can support per-share upside if TPV, churn, and credit losses stabilize, but the 1Q26 release makes the path more execution-sensitive [#6K-1Q26-EX99.1][#IR-GUIDANCE-2026].
Recommendation
No formal recommendation provided.

